About Tragara
Tragara Pharmaceuticals, Inc. is a pharmaceutical company based in San Diego, California focused on the clinical and commercial development of proprietary drugs for the treatment of various cancers. Tragara launched operations in January 2007 and is focusing its development resources on two proprietary compounds: (1) Capoxigem® (apricoxib; TG01), an oral, potent, and selective inhibitor of cyclooxygenase-2 (COX-2) for the treatment of solid tumors including non-small cell lung cancer, breast cancer, and pancreatic cancer and (2) TG02- multikinase inhibitor for the treatment of hematologic and solid tumors.
|
|
|
11-50 employees
View all Tragara employees
|
|
IT Services and IT Consulting
|
|
(760) 208-6900
|
|
San Diego, California
|
|
2007
|
Tragara Alternatives
Frequently Asked Questions about Tragara
Tom Estok is the CEO of Tragara. To contact Tom Estok email at [email protected]. Or you may call +1.8584316000 or (760) 931-0020
The decision makers in Tragara are Claude Amsellem, Cristina Rossi, Marianna Arpaia, etc. Click to Find Tragara decision makers emails.
Tragara Staff Directory
Search Tragara Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
